Genomictree, Inc. (228760) Stock Statistics & Valuation Metrics

Genomictree, Inc. has a market cap or net worth of ₩275.62B. The enterprise value is ―.

Genomictree, Inc. has 24,859,201 shares outstanding. The number of shares has decreased by -2.65% in one year.

Genomictree, Inc.’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -9.52%.

The current PE Ratio of Genomictree, Inc. is ―. Genomictree, Inc.’s PEG ratio is 3.41.

In the last 12 months, Genomictree, Inc. had revenue of 3.76B and earned -8.99B in profits. Earnings per share was -374.27.

In the last 12 months, operating cash flow was -8.80B and capital expenditures -223.61M, giving a free cash flow of -11.60B billion.

Genomictree, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Genomictree, Inc. upcoming earnings date is Aug 7, 2026, TBA (Confirmed).

Genomictree, Inc. as a current ratio of 17.75, with Debt / Equity ratio of 0.04%

In the past 12 months, Genomictree, Inc. has paid 11.47M in taxes.

Genomictree, Inc. EV to EBITDA ratio is -38.82, with an EV/FCF ratio of -40.02.

Genomictree, Inc. has ₩75.39B in cash and marketable securities with ₩55.19M in debt, giving a net cash position of ₩75.33B billion.

Gross margin is 1.21%, with operating margin of -300.47%, and net profit margin of -238.98%.

The average price target for Genomictree, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―